Evidence map›Paper›PMID 25258083›Full record

ArticleScience (New York, N.Y.)2014

mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity.

Shih-Chin Cheng, Jessica Quintin, Robert A Cramer, Kelly M Shepardson, Sadia Saeed, Vinod Kumar, Evangelos J Giamarellos-Bourboulis, Joost H A Martens, Nagesha Appukudige Rao, Ali Aghajanirefah and 18 more

Erratum issued Registry-linked trialAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04348370 (Bacillus Calmette-Guerin Vaccination as Defense Against SARS-CoV-2), which is not on this map. Cited by 1,366 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,366citing papers in PubMed, 1 pooled it
41.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04348370 phase4completednot on this mapstarted 2020, after this paper: background citation

Bacillus Calmette-Guerin Vaccination as Defense Against SARS-CoV-2: A Randomized Controlled Trial to Protect Health Care Workers by Enhanced Trained Immune Responses

TypeinterventionalSponsorTexas A&M UniversityRan2020 to 2023Enrolled659ConditionsCoronavirus, Coronavirus Infection, Coronavirus as the Cause of Diseases Classified ElsewhereArmsBCG Vaccine, Placebo Vaccine
3 · Its place in the literature

Who cites it

1,366 citing papers in PubMed, 1 synthesis or guideline pooled it, 2,074 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Trained Immunity in Childhood Vaccination.Acta paediatrica (Oslo, Norway : 1992) · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Peripheral immune-cell bioenergetics in acute and stable schizophrenia.European archives of psychiatry and clinical neuroscience · 2026
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

1,306 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 9 institutions in 3 countries.

Shih-Chin ChengDepartment of Internal Medicine, Radboud University Medical Center, 6525 GA Nijmegen, Netherlands.
Jessica QuintinDepartment of Internal Medicine, Radboud University Medical Center, 6525 GA Nijmegen, Netherlands.
Robert A CramerDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA.
Kelly M ShepardsonDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA.
Sadia SaeedDepartment of Molecular Biology, Faculties of Science and Medicine, Nijmegen Centre for Molecular Life Sciences, Radboud University, 6500 HB Nijmegen, Netherlands.
Vinod KumarDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Evangelos J Giamarellos-Bourboulis4th Department of Internal Medicine, University of Athens Medical School, 12462 Athens, Greece.
Joost H A MartensDepartment of Molecular Biology, Faculties of Science and Medicine, Nijmegen Centre for Molecular Life Sciences, Radboud University, 6500 HB Nijmegen, Netherlands.
Nagesha Appukudige RaoDepartment of Molecular Biology, Faculties of Science and Medicine, Nijmegen Centre for Molecular Life Sciences, Radboud University, 6500 HB Nijmegen, Netherlands.
Ali AghajanirefahDepartment of Molecular Biology, Faculties of Science and Medicine, Nijmegen Centre for Molecular Life Sciences, Radboud University, 6500 HB Nijmegen, Netherlands.
Ganesh R ManjeriDepartment of Biochemistry, Faculties of Science and Medicine, Nijmegen Centre for Molecular Life Sciences, Radboud University, 6500 HB Nijmegen, Netherlands.
Yang LiDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Daniela C IfrimDepartment of Internal Medicine, Radboud University Medical Center, 6525 GA Nijmegen, Netherlands.
Rob J W ArtsDepartment of Internal Medicine, Radboud University Medical Center, 6525 GA Nijmegen, Netherlands.
Brian M J W van der VeerDepartment of Molecular Biology, Faculties of Science and Medicine, Nijmegen Centre for Molecular Life Sciences, Radboud University, 6500 HB Nijmegen, Netherlands.
Brian M J W van der MeerDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Peter M T DeenDepartment of Physiology, Radboud University Medical Center, 6525 GA Nijmegen, Netherlands.
Colin LogieDepartment of Molecular Biology, Faculties of Science and Medicine, Nijmegen Centre for Molecular Life Sciences, Radboud University, 6500 HB Nijmegen, Netherlands.
Luke A O'NeillSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.
Peter WillemsDepartment of Biochemistry, Faculties of Science and Medicine, Nijmegen Centre for Molecular Life Sciences, Radboud University, 6500 HB Nijmegen, Netherlands.
Frank L van de VeerdonkDepartment of Internal Medicine, Radboud University Medical Center, 6525 GA Nijmegen, Netherlands.
Jos W M van der MeerDepartment of Internal Medicine, Radboud University Medical Center, 6525 GA Nijmegen, Netherlands.
Aylwin NgCenter for Computational and Integrative Biology and Gastrointestinal Unit, Massachusetts General Hospital, Harvard School of Medicine, Boston, MA 02114, USA. Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Leo A B JoostenDepartment of Internal Medicine, Radboud University Medical Center, 6525 GA Nijmegen, Netherlands.
Cisca WijmengaDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Hendrik G StunnenbergDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Ramnik J XavierCenter for Computational and Integrative Biology and Gastrointestinal Unit, Massachusetts General Hospital, Harvard School of Medicine, Boston, MA 02114, USA. Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Mihai G NeteaDepartment of Internal Medicine, Radboud University Medical Center, 6525 GA Nijmegen, Netherlands. mihai.netea@radboudumc.nl.
Radboud University Nijmegen · NLUniversity of Groningen · NLDartmouth College · USRadboud University Medical Center · NLUniversity Medical Center · USUniversity Medical Center Groningen · NLBroad Institute · USMassachusetts General Hospital · USTrinity College Dublin · IE

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
TRANSLATIONAL RESEARCH COREP30GM106394 · NIGMS · DARTMOUTH COLLEGE · PI O'TOOLE, GEORGE A. · 2013 to 2017
$6.1M
Center for Molecular, Cellular, and Translational ImmunologyP30GM103415 · NIGMS · DARTMOUTH COLLEGE · PI GREEN, WILLIAM R · 2012 to 2015
$4.7M
ATG16L1 T300A: genetics to biologyR01DK097485 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI XAVIER, RAMNIK J · 2013 to 2021
$4.1M
Hypoxia Adaptation and Fungal Virulence of Aspergillus fumigatusR01AI081838 · NIAID · MONTANA STATE UNIVERSITY - BOZEMAN · PI CRAMER, ROBERT ANDREW · 2009 to 2017
$2.9M
European Research Council 310372NIAID NIH HHS R01 AI081838NIAID NIH HHS R01AI81838NIDDK NIH HHS DK097485NIDDK NIH HHS DK43351NIDDK NIH HHS P30 DK043351NIDDK NIH HHS R01 DK097485NIGMS NIH HHS 1P30GM106394-01NIGMS NIH HHS 5P30GM103415-03NIGMS NIH HHS P30 GM103415NIGMS NIH HHS P30 GM106394
6 · The paper itself

Abstract

Epigenetic reprogramming of myeloid cells, also known as trained immunity, confers nonspecific protection from secondary infections. Using histone modification profiles of human monocytes trained with the Candida albicans cell wall constituent β-glucan, together with a genome-wide transcriptome, we identified the induced expression of genes involved in glucose metabolism. Trained monocytes display high glucose consumption, high lactate production, and a high ratio of nicotinamide adenine dinucleotide (NAD(+)) to its reduced form (NADH), reflecting a shift in metabolism with an increase in glycolysis dependent on the activation of mammalian target of rapamycin (mTOR) through a dectin-1-Akt-HIF-1α (hypoxia-inducible factor-1α) pathway. Inhibition of Akt, mTOR, or HIF-1α blocked monocyte induction of trained immunity, whereas the adenosine monophosphate-activated protein kinase activator metformin inhibited the innate immune response to fungal infection. Mice with a myeloid cell-specific defect in HIF-1α were unable to mount trained immunity against bacterial sepsis. Our results indicate that induction of aerobic glycolysis through an Akt-mTOR-HIF-1α pathway represents the metabolic basis of trained immunity.

Indexed as

Epigenesis, GeneticAerobiosisAnimalsbeta-GlucansCandida albicansCandidiasisDisease Models, AnimalFemaleGlucoseGlycolysisHumansHypoxia-Inducible Factor 1, alpha SubunitImmunity, InnateImmunologic MemoryMaleMicebeta-GlucansGlucoseHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitmTOR protein, mouseTOR Serine-Threonine Kinases

Identifiers

PMID25258083
PMCPMC4226238
OpenAlexW2067031028

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.